#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Metabolic disorder Pancreatic neuroendocrine tumour Biotinidase deficiency Infantile spasms Gaucher's disease type III Carcinoid tumour Antisynthetase syndrome Muscular dystrophy Gastroenteropancreatic neuroendocrine tumour disease Bone marrow disorder Primary biliary cholangitis Obliterative bronchiolitis Emphysema Short-bowel syndrome Retinopathy proliferative More trials…

    Learn about Rare Diseases

    Chondrosarcoma metastatic – Trials in Disease Cystic fibrosis – Treatment Hepatic angiosarcoma – Basic Information Idiopathic pulmonary fibrosis Haemophagocytic lymphohistiocytosis – Trials in Disease Toxic epidermal necrolysis – Diagnostics Haemophagocytic lymphohistiocytosis Alternating hemiplegia of childhood – Trials in Disease Hereditary hypophosphataemic rickets Alternating hemiplegia of childhood – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lapatinib Mycophenolate Sodium Clavulanic Acid LTX-002 SODIUM Tenofovir Disoproxil Maribavir Mezigdomide Ramucirumab Zidesamtinib Nicotinamide ANERATRIGINE MESILATE Oseltamivir Caspofungin Acetate Myrrh Tenofovir Alafenamide Cangrelor Tetrasodium Minocycline Hydrochloride Aminocaproic Acid Theophylline Opelconazole More therapies…

    Learn about Your Condition

    Vulval cancer recurrent Renal cancer recurrent T-cell lymphoma Breast cancer Neurotrophic keratopathy Diverticulitis Chondrosarcoma Bronchopulmonary aspergillosis Tooth loss Aicardi-Goutieres syndrome Plasma cell myeloma recurrent Biopsy heart Ovarian cancer recurrent Vascular graft thrombosis Vertebrobasilar stroke More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Female Urogenital Diseases and Pregnancy Complications

  • Study of oxycodone safety and effectiveness for pain relief during labor and its effects on newborns

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Labour pain
    Investigated Drugs:
    • Oxycodone Hydrochloride Trihydrate
    Finland

  • Study of leuprorelin and progestogen treatment in women with adenomyosis undergoing assisted reproductive technology to improve pregnancy outcomes

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Leuprorelin Acetate
    Italy

  • Study on the Safety and Tolerability of TUB-040 for Patients with Platinum-Resistant Ovarian Cancer or Relapsed/Refractory Non-Small Cell Lung Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Adenocarcinoma
    • Ovarian cancer
    • Non-small cell lung cancer
    Investigated Drugs:
    • Tub-040
    Belgium Germany Romania Spain

  • Study on M2RLAB Cell Therapy for Treating Acute Kidney Injury in Patients After Heart Surgery

    Recruiting

    2 1
    Investigated Drugs:
    • M2Rlab
    Spain

  • Study on the Impact of Exercise and Atorvastatin on Advanced Breast, Ovarian, Prostate, and Kidney Cancer Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian cancer metastatic
    • Renal cancer
    • Prostate cancer metastatic
    Investigated Drugs:
    • Atorvastatin
    Finland

  • Study on Letrozole Maintenance Therapy for Patients with Epithelial Ovarian Cancer

    Recruiting

    3 1 1
    Investigated Diseases:
    • Ovarian epithelial cancer
    Investigated Drugs:
    • Letrozole
    Austria Germany
Previous Page
1 … 7 8 9 10 11 … 32
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!